Today: 11 April 2026
Browse Category

NYSE:LLY 20 July 2025 - 23 August 2025

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

The FDA approved Ionis Pharmaceuticals’ Dawnzera as the first RNA-targeted therapy to prevent hereditary angioedema attacks, priced at about $57,462 per dose. AbbVie’s Rinvoq met key endpoints in a second Phase 3 alopecia areata trial, while Scholar Rock’s apitegromab showed significant motor gains in spinal muscular atrophy. Gilead’s Kite Pharma will acquire Interius BioTherapeutics for $350 million.
Tariff Tsunami, Tech Tumble & Peace Talk Buzz – Global Business Roundup (Aug 19–20, 2025)

Tariff Tsunami, Tech Tumble & Peace Talk Buzz – Global Business Roundup (Aug 19–20, 2025)

Nvidia shares fell sharply on August 19, 2025, as a tech selloff pulled the Nasdaq down 1.5%. President Trump met Ukraine’s president and pledged U.S. support for Ukraine’s security in any peace deal. The U.S. Commerce Department expanded 232 tariffs to 407 new categories, affecting over $200 billion in imports. New Zealand’s central bank cut rates to 3.00%, sending the kiwi dollar to $0.584.
Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy became the first GLP-1 therapy approved by the FDA for MASH, affecting about 5% of U.S. adults. Tonix’s Tonmya was cleared for fibromyalgia, the first new therapy in 15 years. Pfizer’s inclacumab failed a key sickle cell trial, and Oxbryta was withdrawn. BioNTech agreed to acquire CureVac in a $1.25 billion all-stock deal.
AI Stock Frenzy: Big Tech Bets, Billion-Dollar Deals & Market Shifts (Aug 15–16, 2025)

AI Stock Frenzy: Big Tech Bets, Billion-Dollar Deals & Market Shifts (Aug 15–16, 2025)

Bridgewater more than doubled its Nvidia stake in Q2 2025, while Tiger Global bought millions more Amazon shares and raised bets on Alphabet, Nvidia, Microsoft, and Meta. On August 14, Oracle and Google Cloud announced a partnership to offer Gemini AI models via Oracle Cloud. Insiders said OpenAI is in talks to sell $6 billion in shares at a $500 billion valuation. Tesla shelved its Dojo AI supercomputer and will rely on Nvidia GPUs.
Global Business Pulse: Markets Juggle Tariffs, Rate Cuts & Mega-Deals (Aug 7–8, 2025)

Global Business Pulse: Markets Juggle Tariffs, Rate Cuts & Mega-Deals (Aug 7–8, 2025)

The United States imposed 100% tariffs on imported chips and electronics Aug. 7, sending Apple shares up 3%. Dow Jones fell 0.5%, S&P 500 slipped 0.1%, and Nasdaq hit a record, while Eli Lilly dropped 14% on weak drug data. The Bank of England cut rates for a fourth time, lifting the pound 0.7%. Paramount Global and Skydance completed an $8.4 billion merger.
From Foldable Phones to Moon Missions: The Biggest Tech News Roundup (July 29–30, 2025)

From Foldable Phones to Moon Missions: The Biggest Tech News Roundup (July 29–30, 2025)

Samsung unveiled the Galaxy Z Fold7 at $1,999 and the Flip7 FE at $899, with the Fold7 26% thinner and 10% lighter than last year’s model. Opera filed an antitrust complaint in Brazil against Microsoft over Edge’s default status. Sony sued Tencent, alleging Light of Motiram copied Horizon Zero Dawn. Figma raised its IPO price range, targeting an $18.8 billion valuation.
Blast-Off Breakthroughs: Fusion Lasers, Space Feats & Tech Triumphs in Weekend Roundup (July 19–20, 2025)

Blast-Off Breakthroughs: Fusion Lasers, Space Feats & Tech Triumphs in Weekend Roundup (July 19–20, 2025)

SpaceX launched 24 Starlink satellites from California on July 18, bringing the active constellation to nearly 8,000. Raytheon delivered OCX GPS control software to the U.S. Space Force. Senate appropriators voted to restore funding for NASA Earth science and exploration missions in the 2026 budget. China unveiled a fusion laser facility in Mianyang, about 50% larger than the U.S. National Ignition Facility.
1 10 11 12

Stock Market Today

  • XRP Rises as Japan Classifies Token as Financial Asset, Boosting Market Sentiment
    April 11, 2026, 11:29 AM EDT. Ripple's XRP gained to $1.35 after Japan's cabinet approved a bill classifying the token as a financial instrument under the Financial Instruments and Exchange Act. This regulatory clarity, set to take effect in fiscal 2027, reduces legal uncertainty for Japanese banks-over 80% of which connect with Ripple's network-and fuels investor optimism. XRP's market cap stood at $82.6 billion with a 26% drop in trading volume to $1.77 billion over 24 hours. Positive sentiment is also driven by potential U.S. regulatory progress with the CLARITY Act, expected in late April, which could facilitate inflows into crypto ETFs. Technical analysts point to cautious bullish momentum, with short-term trading between $1.30 and $1.40, and longer-term targets suggesting substantial upside. These developments position XRP for stronger institutional use and growth in cross-border payments.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 11:42 AM EDT XRP Rises as Japan Classifies Token as Financial Asset, Boosting Market Sentiment April 11, 2026, 11:29 AM EDT. Ripple's XRP gained to $1.35 after Japan's cabinet approved a bill classifying the token as a financial instrument under the Financial Instruments and Exchange Act. This regulatory clarity, set to take effect in fiscal 2027, reduces legal uncertainty for Japanese banks-over 80% of which connect with Ripple's network-and fuels investor optimism. XRP's market cap stood at $82.6 billion with a 26% drop in trading volume to $1.77
UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

UK Stock Market Today: FTSE 100 Climbs as Traders Eye Fragile Iran Ceasefire

10 April 2026
London’s FTSE 100 rose 0.38% to 10,644.28 late Friday morning as investors awaited U.S.-Iran talks in Pakistan. Brent crude climbed 1% to $96.83 a barrel, while sterling eased but was on track for its biggest weekly gain since January. The FTSE 250 gained 0.79%. Britain’s 10-year gilt yield stood at 4.807%.
US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

US Stock Market Today: CPI, Oil and Iran Truce Set the Tone Before the Open

10 April 2026
Dow e-minis slipped 0.15% before Friday’s open, with S&P 500 and Nasdaq 100 futures each down 0.08% as traders awaited March CPI data and watched U.S.-Iran tensions. Economists expect headline CPI to rise 0.9% for March and 3.3% year-on-year. Weekly jobless claims increased to 219,000. Brent crude traded near $97 a barrel, while shipping through the Strait of Hormuz remained well below normal.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 10.04.2026

10 April 2026
LIVEMarkets rolling coverageStarted: April 10, 2026, 12:00 AM EDTUpdated: April 10, 2026, 11:59 PM EDT Orora ASX:ORA Faces Earnings Reset After Saverglass Impact and Middle East Disruptions April 10, 2026, 11:59 PM EDT. Orora (ASX:ORA) shares plunged over 8% in one day following a guidance update that revealed an earnings reset at its Saverglass unit due to Middle East supply chain disruptions and a shutdown at the Ras Al Khaimah glass plant. Despite a sharp short-term loss, Orora's 90-day share price rise exceeds 33%, contrasting a longer-term 10.58% annual total shareholder return decline amid ongoing sector pressures. Trading at A$1.49,
Go toTop